TBE Vaccination Breakthrough Cases—Does Age Matter?

• Main Authors: Heinz-J. Schmitt, Gerhard Dobler, Dace Zavadska, Zane Freimane, Dimitrios Fousteris, Wilhelm Erber, Luis Jodar, Andreas Palmborg
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Vaccines
• Subjects: tick-borne encephalitis; vaccine failure; vaccination failure; older adults; Sweden
• Online Access: https://www.mdpi.com/2076-393X/9/8/932

Tick-borne encephalitis (TBE) vaccines are highly effective in preventing TBE and vaccine failures (VF) are rare events. In this study, we compared the age distribution of TBE cases and TBE VF in three endemic countries: Sweden, Southern Germany, and Latvia. While the age distribution of TBE cases was similar for those <50 years versus those ≥50 years in all three countries, in Sweden, a higher proportion of VF cases was ≥50 years, whereas most VF cases in Latvia were <50 years of age and more evenly distributed between those <50 years versus those ≥50 in Southern Germany. Here, theoretical explanations were provided, including differences in diagnostic practices, vaccine uptake between age groups, behavioral patterns and underlying medical conditions, as to why VF were generally older in Sweden than the other countries. There is no scientific rationale to give an extra priming dose of TBE vaccine to subjects ≥50 years of age.